IPO registrations (S-1, F-1) · Registrants
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- SEC CIK
- 1299130 · filings on EDGAR ↗
- Name on the registration
- PACIFIC BIOSCIENCES OF CALIFORNIA INC
- Former names
- PACIFIC BIOSCIENCES OF CALIFORNIA INC (2005–2013); NANOFLUIDICS INC (2004–2004)
- Registration
- Form S-1, first filed 2010-08-16, last 2010-10-22; 1 initial registration, 6 amendments
- Outcome
- Final prospectus filed 2010-10-27; declared effective 2010-10-26
- Industry (SIC)
- Laboratory Analytical Instruments 3826
- Incorporated in
- DE
- Business address
- 1305 O'BRIEN DRIVE, Menlo Park, CA 94025
- EIN
- 16-1590339
- Ticker
- PACB (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC. on the corporate pages
Offering terms
- Final price
- $16.00 per share (424B1 filed 2010-10-27, an initial public offering)
- Shares sold
- 12,500,000
- Gross proceeds
- $200,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol PACB
- Lead underwriters
- J.P. Morgan
- Syndicate
- Morgan Stanley; Deutsche Bank; Piper Sandler
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: Pacific Biosciences of California, Inc. Fuzzy (name and state)
- Business registration: Pacific Biosciences of California, Inc. Fuzzy (name and state)
- Business registration: PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Fuzzy (name and state)
- Form 5500 plan sponsor: PACIFIC BIOSCIENCES OF CALIFORNIA, INC. EXACT (EIN (EXACT))
- Federal award recipient: PACIFIC BIOSCIENCES OF CALIFORNIA, INC Fuzzy (name and state)
- Form D issuer: PACIFIC BIOSCIENCES OF CALIFORNIA, INC. EXACT (CIK (EXACT))
- Lobbying client: PACIFIC BIOSCIENCES OF CALIFORNIA, INC Fuzzy (name and state)
- Lobbying client: PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Fuzzy (name and state)
- SEC filer: PACIFIC BIOSCIENCES OF CALIFORNIA INC EXACT (CIK (EXACT))
- Person page: Brook H Byers Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: David W Meline Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 10
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2010-08-16 | S-1 | S-1 (registration) | PACIFIC BIOSCIENCES OF CALIFORNIA INC | 0001193125-10-189512 ↗ |
| 2010-09-20 | S-1/A | S-1/A (amendment) | PACIFIC BIOSCIENCES OF CALIFORNIA INC | 0001193125-10-212498 ↗ |
| 2010-10-01 | S-1/A | S-1/A (amendment) | PACIFIC BIOSCIENCES OF CALIFORNIA INC | 0001193125-10-221497 ↗ |
| 2010-10-05 | S-1/A | S-1/A (amendment) | PACIFIC BIOSCIENCES OF CALIFORNIA INC | 0001193125-10-223151 ↗ |
| 2010-10-19 | S-1/A | S-1/A (amendment) | PACIFIC BIOSCIENCES OF CALIFORNIA INC | 0001193125-10-231219 ↗ |
| 2010-10-20 | S-1/A | S-1/A (amendment) | PACIFIC BIOSCIENCES OF CALIFORNIA INC | 0001193125-10-232744 ↗ |
| 2010-10-22 | S-1/A | S-1/A (amendment) | PACIFIC BIOSCIENCES OF CALIFORNIA INC | 0001193125-10-234059 ↗ |
| 2010-10-26 | EFFECT | EFFECT (declared effective) | PACIFIC BIOSCIENCES OF CALIFORNIA INC | 9999999995-10-003049 ↗ |
| 2010-10-27 | 424B1 | 424B1 (final prospectus) | PACIFIC BIOSCIENCES OF CALIFORNIA INC | 0001193125-10-237221 ↗ |
| 2012-05-01 | EFFECT | EFFECT (declared effective) | PACIFIC BIOSCIENCES OF CALIFORNIA INC | 9999999995-12-001366 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2010-10-22 | S-1/A | registration statement | 9,384,851 | - | 0 | primary document; shares headline | document ↗ | |||
| 2010-10-27 | 424B1 | final prospectus | $16.00 | 12,500,000 | $200,000,000 | Nasdaq PACB | 4 | primary document; price sentence, shares headline, proceeds table, cover names 4 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| BARNES SUSAN K | Officer | EVP, CFO and PAO; EVP & Chief Financial Officer; SVP & Chief Financial Officer | 14 | 2010–2020 | |
| BYERS BROOK H | Director | 11 | 2010–2016 | person page Fuzzy | |
| Dow Brian B | Officer | VP and PAO | 6 | 2010–2015 | |
| Ericson William W. | Director | 39 | 2010–2026 | ||
| Hunkapiller Michael | Director; Director,Officer | CEO & President; Chairman, CEO & President | 37 | 2010–2021 | |
| LIVINGSTON RANDALL S | Director | 18 | 2010–2026 | ||
| Martin Hugh C | Director; Director,Officer | Chairman, CEO & President | 3 | 2010–2012 | |
| Phillips James Michael | Officer | SVP, Research & Development | 23 | 2010–2020 | |
| SIEGEL SUSAN E | Director | 5 | 2010–2012 | ||
| SINGER DAVID B | Director | 4 | 2010–2012 | ||
| Turner Stephen W | Officer | Chief Technology Officer; VP & Chief Technology Officer | 4 | 2010–2011 | |
| Glynn Michael | Officer | Chief Commercial Officer | 2 | 2011–2012 | |
| MOHR MARSHALL | Director | 20 | 2012–2026 | ||
| CORCORAN KEVIN P | Officer | SVP, Market Development | 12 | 2012–2017 | |
| Botstein David | Director | 13 | 2012–2023 | ||
| Shapiro Lucy | Director | 16 | 2012–2025 | ||
| MILLIGAN JOHN F | Director; DirectorOther | 16 | 2013–2026 | ||
| ORDONEZ KATHY | Director; Director,Officer | Chief Commercial Officer | 19 | 2014–2026 | |
| HENRY CHRISTIAN O | Director; Director,Officer; DirectorOther; Officer | Chief Executive Officer; President & CEO; See Remarks | 28 | 2018–2026 | |
| Seipert Christopher J. | Officer | VP, Sales, Service & Support | 1 | 2020 | |
| Zaccarin Denis | Officer | SVP, Research & Development | 1 | 2020 | |
| Schaefer Eric | Officer | Chief Accounting Officer; VP Chief Accounting Officer | 3 | 2020–2021 | |
| Gong Benjamin B | Officer | Interim CFO and PAO | 1 | 2020 | |
| Kim Susan G. | Officer | Chief Financial Officer; See Remarks | 14 | 2020–2024 | |
| Fromen Peter | Officer | Chief Commercial Officer; See Remarks | 4 | 2021–2022 | |
| Van Oene Mark | Officer | Chief Operating Officer; See Remarks | 23 | 2021–2026 | |
| Farmer Michele | Officer | Chief Accounting Officer; See Remarks | 17 | 2021–2026 | |
| Valantine Hannah | Director | 7 | 2021–2026 | ||
| Eidel Jeff | Officer | See Remarks | 8 | 2022–2024 | |
| Meline David W | Director | 4 | 2023–2024 | person page Fuzzy | |
| Smith Christopher M | Director | 4 | 2025–2026 | ||
| Gibson James R II | Officer | See Remarks | 4 | 2025–2026 | |
| Gibson Christopher | Director | 4 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2023-10-19 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Other Technology | $84,760,527 | $84,760,527 | 165 | 1 |
| 2023-08-17 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Other Technology | $85,000,000 | $85,000,000 | 47 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | Pacific Biosciences of California, Inc. | CA | State business registries | name and state |
| Business registration | Pacific Biosciences of California, Inc. | CA | State business registries | name and state |
| Business registration | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | CA | State business registries | name and state |
| Federal award recipient | PACIFIC BIOSCIENCES OF CALIFORNIA, INC | CA | Federal spending (USAspending) | name and state |
| Form D issuer | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | CA | Form D private offerings | CIK (EXACT) |
| Lobbying client | PACIFIC BIOSCIENCES OF CALIFORNIA, INC | CA | Federal lobbying (LDA) | name and state |
| Lobbying client | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | CA | Federal lobbying (LDA) | name and state |
| Patent assignee | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | CA | Patents (USPTO) | name and state |
| SEC filer | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Pacific Biosciences of California, Inc. | CA | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | EIN (EXACT) | ||
| Person page | Brook H Byers | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | David W Meline | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Laboratory Analytical Instruments, CA first:
- NGEN, INC. CA
- CEPHEID CA
- LJL BIOSYSTEMS INC CA
- AGILENT TECHNOLOGIES, INC. CA
- ILLUMINA, INC. CA
- QPC Lasers CA
- WaferGen Bio-systems, Inc. CA
- PROTEINSIMPLE CA
- Bionano Genomics, Inc. CA
- AutoGenomics, Inc. CA
In other datasets, the same topic (Technology) in CA:
- Lobbying client: 8X8, INC. (Federal lobbying (LDA))
Interests: Laboratory Analytical Instruments · Technology